Lyme Disease and Relapsing Fever Spirochetes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Communicable Disease Control
LECTURE NOTES For Nursing Students Communicable Disease Control Mulugeta Alemayehu Hawassa University In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education 2004 Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00. Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education. Important Guidelines for Printing and Photocopying Limited permission is granted free of charge to print or photocopy all pages of this publication for educational, not-for-profit use by health care workers, students or faculty. All copies must retain all author credits and copyright notices included in the original document. Under no circumstances is it permissible to sell or distribute on a commercial basis, or to claim authorship of, copies of material reproduced from this publication. ©2004 by Mulugeta Alemayehu All rights reserved. Except as expressly provided above, no part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission of the author or authors. This material is intended for educational use only by practicing health care workers or students and faculty in a health care field. Communicable Disease Control Preface This lecture note was written because there is currently no uniformity in the syllabus and, for this course additionally, available textbooks and reference materials for health students are scarce at this level and the depth of coverage in the area of communicable diseases and control in the higher learning health institutions in Ethiopia. -
First Cases of Natural Infections with Borrelia Hispanica in Two Dogs and a Cat from Europe
microorganisms Case Report First Cases of Natural Infections with Borrelia hispanica in Two Dogs and a Cat from Europe 1, , 2, 2 3 3 Gabriele Margos * y, Nikola Pantchev y, Majda Globokar , Javier Lopez , Jaume Rodon , Leticia Hernandez 3, Heike Herold 4 , Noelia Salas 3, Anna Civit 3 and Volker Fingerle 1 1 German National Reference Centre for Borrelia, Bavarian Health and Food Safety Authority, 85764 Oberschleißheim, Germany; volker.fi[email protected] 2 IDEXX Laboratories, 70806 Kornwestheim, Germany; [email protected] (N.P.); [email protected] (M.G.) 3 IDEXX Laboratories, 08038 Barcelona, Spain; [email protected] (J.L.); [email protected] (J.R.); [email protected] (L.H.); [email protected] (N.S.); [email protected] (A.C.) 4 Bavarian Health and Food Safety Authority, 85764 Oberschleißheim, Germany; [email protected] * Correspondence: [email protected] These authors contributed equally to this work. y Received: 21 July 2020; Accepted: 14 August 2020; Published: 18 August 2020 Abstract: Canine cases of relapsing fever (RF) borreliosis have been described in Israel and the USA, where two RF species, Borrelia turicatae and Borrelia hermsii, can cause similar clinical signs to the Borrelia persica in dogs and cats reported from Israel, including fever, lethargy, anorexia, thrombocytopenia, and spirochetemia. In this report, we describe the first clinical cases of two dogs and a cat from Spain (Cordoba, Valencia, and Seville) caused by the RF species Borrelia hispanica. Spirochetes were present in the blood smears of all three animals, and clinical signs included lethargy, pale mucosa, anorexia, cachexia, or mild abdominal respiration. -
United States Patent [191 [11] Patent Number: 5,403,718 Durward Et Al
. US005403718A United States Patent [191 [11] Patent Number: 5,403,718 Durward et al. [451 Date of Patent: * Apr. 4, 1995 [54] METHODS AND ANTIBODIES FOR THE I OTHER PUBLICATIONS IMMUNE CAPTURE AND DETECHON 0F Nowinski et al, Science, 219:637-644 (11 Feb. 1983), BQRRELI-A BURGDORFERI - “Monoclonal Antibodies for Diagnosis of Infectious [76] Inventors: David W. Dorward, 401 N. 7th St; Diseases in Humans”. Tom G. Schwan, 601 S. 5th St.; . E . _ 1 E . Claude F. Garon, 904 Ponderosa Dr., Primary xammer Caro ' Bldwen all of Hamilton, Mont. 59840 [57] ABSTRACT [ * ] Notice; The portion of the term of this patent The invention relates to novel antigens associated with subsequent to Jun, 8, 2010 has been Borrelia burgdorferi which are exported (or shed) in disclaimed. vivo and whose detection is a means of diagnosing _ Lyme disease. The antigens are extracellular membrane [211 App 1' No" 929’172 vesicles and other bioproducts including the major ex [22] Filed: Aug. 11,1992 tracellular protein. The invention further provides anti bodies, monoclonal and/or polyclonal, labeled and/or Related US. Application Data unlabeled, that react with the antigens. The invention [63] Continuation-impart ofSer. No. 485 551 Feb. 27 1990 . relates to a math“ for immune capture of Speci?c mi‘ Pat No_ 5,217,871 ’ ’ ’ ’ , croorganisms for their subsequent cultivation. The in vention is also directed to a method of diagnosing Lyme clci? ------------------ -- GolN 332940 disease by detecting the antigens in a biological sample . ................................ .. , . , taken from a host using the antibodies in conventional 530/3871; 530/388.4; 530/3895 immunoassay formats. -
Lyme Disease: Diversity of Borrelia Species in California and Mexico Detected Using a Novel Immunoblot Assay
healthcare Article Lyme Disease: Diversity of Borrelia Species in California and Mexico Detected Using a Novel Immunoblot Assay Melissa C. Fesler 1, Jyotsna S. Shah 2, Marianne J. Middelveen 3, Iris Du Cruz 2, Joseph J. Burrascano 2 and Raphael B. Stricker 1,* 1 Union Square Medical Associates, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA; [email protected] 2 IGeneX Reference Laboratory, Milpitas, CA 95035, USA; [email protected] (J.S.S.); [email protected] (I.D.C.); [email protected] (J.J.B.) 3 Atkins Veterinary Services, Calgary, AB, T3B 4C9, Canada; [email protected] * Correspondence: [email protected] Received: 7 March 2020; Accepted: 10 April 2020; Published: 14 April 2020 Abstract: Background: With more than 300,000 new cases reported each year in the United States of America (USA), Lyme disease is a major public health concern. Borrelia burgdorferi sensu stricto (Bbss) is considered the primary agent of Lyme disease in North America. However, multiple genetically diverse Borrelia species encompassing the Borrelia burgdorferi sensu lato (Bbsl) complex and the Relapsing Fever Borrelia (RFB) group are capable of causing tickborne disease. We report preliminary results of a serological survey of previously undetected species of Bbsl and RFB in California and Mexico using a novel immunoblot technique. Methods: Serum samples were tested for seroreactivity to specific species of Bbsl and RFB using an immunoblot method based on recombinant Borrelia membrane proteins, as previously described. A sample was recorded as seropositive if it showed immunoglobulin M (IgM) and/or IgG reactivity with at least two proteins from a specific Borrelia species. -
Interaction Between Borrelia Miyamotoi Variable Major Proteins Vlp15/16 and Vlp18 with Plasminogen and Complement Frederik L
www.nature.com/scientificreports OPEN Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement Frederik L. Schmidt1,5, Valerie Sürth1,5, Tim K. Berg1,5, Yi‑Pin Lin2,3, Joppe W. Hovius4 & Peter Kraiczy1* Borrelia miyamotoi, a relapsing fever spirochete transmitted by Ixodid ticks causes B. miyamotoi disease (BMD). To evade the human host´s immune response, relapsing fever borreliae, including B. miyamotoi, produce distinct variable major proteins. Here, we investigated Vsp1, Vlp15/16, and Vlp18 all of which are currently being evaluated as antigens for the serodiagnosis of BMD. Comparative analyses identifed Vlp15/16 but not Vsp1 and Vlp18 as a plasminogen‑interacting protein of B. miyamotoi. Furthermore, Vlp15/16 bound plasminogen in a dose‑dependent fashion with high afnity. Binding of plasminogen to Vlp15/16 was signifcantly inhibited by the lysine analog tranexamic acid suggesting that the protein–protein interaction is mediated by lysine residues. By contrast, ionic strength did not have an efect on binding of plasminogen to Vlp15/16. Of relevance, plasminogen bound to the borrelial protein cleaved the chromogenic substrate S‑2251 upon conversion by urokinase‑type plasminogen activator (uPa), demonstrating it retained its physiological activity. Interestingly, further analyses revealed a complement inhibitory activity of Vlp15/16 and Vlp18 on the alternative pathway by a Factor H‑independent mechanism. More importantly, both borrelial proteins protect serum sensitive Borrelia garinii cells from complement‑mediated lysis suggesting multiple roles of these two variable major proteins in immune evasion of B. miyamotoi. Borrelia (B.) miyamotoi is a vector-borne human pathogenic spirochete transmitted by ixodid ticks and causes the so-called hard tick-borne relapsing fever (HTBRF) or B. -
Diagnosis and Management of Borrelia Turicatae Infection In
RESEARCH LETTERS Diagnosis and Management along his left leg and a small lesion at his urethral me- atus. He denied any history of genital lesions and had not of Borrelia turicatae Infection seen any biting insects. After 6 days, the lesions sponta- in Febrile Soldier, Texas, USA neously resolved. In a Texas emergency department, the initial diagnosis was viral syndrome, and a rapid influenza test result was Anna M. Christensen, Elizabeth Pietralczyk, negative. The fever persisted despite administration of an- Job E. Lopez, Christopher Brooks, tipyretics. After 2 days, the patient returned to the hospital, Martin E. Schriefer, Edward Wozniak, where he received only symptomatic treatment. No tests Benjamin Stermole were ordered. After another 2 days, he sought care from his Author affiliations: Eglin Air Force Base, Valparaiso, Florida, USA unit physician. Laboratory tests showed marked thrombo- (A.M. Christensen, E. Pietralczyk, C. Brooks, B. Stermole); Baylor cytopenia with 16 × 109 platelets/L (reference range 150– College of Medicine and Texas Children’s Hospital, Houston, 400 × 109 platelets/L). Spirochetes were seen on peripheral Texas, USA (J.E. Lopez); Centers for Disease Control and blood smear (online Technical Appendix Figure 2). He was Prevention, Fort Collins, Colorado, USA (M.E. Schriefer); Texas referred for hospital admission. Physical examination find- State Guard, San Antonio, Texas, USA (E. Wozniak) ings were unremarkable: no splenomegaly, hepatomegaly, or rash. Blood cultures and serologic testing for rickettsiae, DOI: http://dx.doi.org/10.3201/eid2305.162069 HIV, dengue virus, Treponema pallidum, and plasmodia produced negative results. Erythrocyte sedimentation rate In August 2015, a soldier returned from field exercises in (58 mm/h) and C-reactive protein level (>19 mg/L) were Texas, USA, with nonspecific febrile illness. -
Pathogen and Host Response Dynamics in a Mouse Model of Borrelia Hermsii Relapsing Fever
veterinary sciences Article Pathogen and Host Response Dynamics in a Mouse Model of Borrelia hermsii Relapsing Fever Christopher D. Crowder, Arash Ghalyanchi Langeroudi, Azadeh Shojaee Estabragh, Eric R. G. Lewis, Renee A. Marcsisin and Alan G. Barbour * Departments of Microbiology & Molecular Genetics and Medicine, University of California Irvine, Irvine, CA 92697, USA; [email protected] (C.D.C.); [email protected] (A.G.L.); [email protected] (A.S.E.); [email protected] (E.R.G.L.); [email protected] (R.A.M.) * Correspondence: [email protected]; Tel.: +1-949-824-5626 Academic Editor: Ulrike Munderloh Received: 13 July 2016; Accepted: 24 August 2016; Published: 30 August 2016 Abstract: Most Borrelia species that cause tick-borne relapsing fever utilize rodents as their natural reservoirs, and for decades laboratory-bred rodents have served as informative experimental models for the disease. However, while there has much progress in understanding the pathogenetic mechanisms, including antigenic variation, of the pathogen, the host side of the equation has been neglected. Using different approaches, we studied, in immunocompetent inbred mice, the dynamics of infection with and host responses to North American relapsing fever agent B. hermsii. The spirochete’s generation time in blood of infected mice was between 4–5 h and, after a delay, was matched in rate by the increase of specific agglutinating antibodies in response to the infection. After initiating serotype cells were cleared by antibodies, the surviving spirochetes were a different serotype and, as a population, grew more slowly. The retardation was attributable to the host response and not an inherently slower growth rate. -
Characteristics of Borrelia Hermsii Infection in Human Hematopoietic Stem Cell-Engrafted Mice Mirror Those of Human Relapsing Fever
Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever Raja Vuyyuru, Hongqi Liu, Tim Manser1, and Kishore R. Alugupalli1 Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107 Edited* by Jeffrey V. Ravetch, The Rockefeller University, New York, NY, and approved November 14, 2011 (received for review June 13, 2011) Rodents are natural reservoirs for a variety of species of Borrelia Four phenotypically and functionally distinct B-cell subsets that cause relapsing fever (RF) in humans. The murine model of have been described in mice: follicular (FO or B2), marginal zone this disease recapitulates many of the clinical manifestations of (MZ), B1a, and B1b (16, 17). The latter three subsets can effi- the human disease and has revealed that T cell-independent anti- ciently mount T cell-independent responses (16, 17). We have body responses are required to resolve the bacteremic episodes. previously shown that mice deficient in B1a cells control infections However, it is not clear whether such protective humoral re- by both the highly virulent B. hermsii strain DAHp-1 (which grows sponses are mounted in humans. We examined Borrelia hermsii to >104/μL blood) as well as an attenuated strain DAH-p19 (which infection in human hematopoietic stem cell-engrafted nonobese was generated by serial in vitro passage of DAH-p1 and reaches diabetic/SCID/IL-2Rγnull mice: “human immune system mice” (HIS- ∼103/μL blood) (12). In contrast, concurrent with the resolution of mice). Infection of these mice, which are severely deficient in lym- DAHp-1 and DAH-p19 bacteremia, B1b cells in the peritoneal − − phoid and myeloid compartments, with B. -
Practice of Medicine Infections
PRACTICE OF MEDICINE INFECTIONS Dr. Sunila MD (Hom) Medical Officer,Department of Homeopathy Govt of Kerala Infection: Lodging & multiplication of the organisms in or on the tissues of host. Primary infection: Initial infection of a host by a parasite. Reinfection: Subsequent infections by the same parasite in the same host. Secondary infection: Infection by another organism in a person suffering from an infectious disease. Nosocomial infection: Cross infections occurring in hospitals. Superinfections: Infections caused by a commensal bacterium in patients who receive intensive chemotherapy. Opportunistic infections: Organisms that ordinarily do not cause disease in healthy persons may affect individuals with diminished resistance. Latent infections: When a pathogen remains in a tissue without producing any disease, but leads to disease when the host resistance is lowered. Commonest infective disease: common cold. PYREXIA OF UNKNOWN ORIGION (PUO) When the temperature is raised above 38.3°C for more than 2 weeks without the cause being detected by physical examination or laboratory tests → PUO (FUO) Etiology a) Occult tuberculosis b) Chronic suppurative lesions of the liver, pelvic organs, urinary tract, peritoneum, gall bladder, brain, lungs, bones & joints & dental sepsis (occasionally). c) Viral infections: Viral hepatitis Infectious mononucleosis Cytomegalovirus infection Aids d) Connective tissue disorders: Giant cell arteritis. RA Rheumatic fever SLE PAN (polyarteritis nodosa) e) Chronic infections: Syphilis Hepatic amoebiasis Cirrhosis liver Malaria Filariasis Leprosy Brucellosis Sarcoidosis f) Haematological malignancies Leukemia Lymphoma Multiple myeloma g) Other malignant lesions: Tumours of lungs, kidney etc. h) Allergic conditions www.similima.com Page 1 i) Miscellaneous conditions: Hemolytic anaemia, dehydration in infants etc. j) Factitious fever: Self induced fever in patients with psychological abnormalities. -
TBRF Risk Among Cavers Austin 2017
Received: 16 January 2019 | Revised: 24 April 2019 | Accepted: 6 May 2019 DOI: 10.1111/zph.12588 ORIGINAL ARTICLE WILEY Evaluating the risk of tick-borne relapsing fever among occupational cavers—Austin, TX, 2017 Stefanie B. Campbell1 | Anna Klioueva2 | Jeff Taylor2 | Christina Nelson1 | Suzanne Tomasi3 | Adam Replogle1 | Natalie Kwit1 | Christopher Sexton1 | Amy Schwartz1 | Alison Hinckley1 1Centers for Disease Control and Prevention, Fort Collins, Colorado Abstract 2Austin Public Health, Austin, Texas Tick-borne relapsing fever (TBRF) is a potentially serious spirochetal infection caused 3Centers for Disease Control and by certain species of Borrelia and acquired through the bite of Ornithodoros ticks. In Prevention, Morgantown, West Virginia 2017, Austin Public Health, Austin, TX, identified five cases of febrile illness among Correspondence employees who worked in caves. A cross-sectional serosurvey and interview were Stefanie B. Campbell, Centers for Disease Control and Prevention, Fort Collins, CO. conducted for 44 employees at eight organizations that conduct cave-related work. Email: [email protected] Antibodies against TBRF-causing Borrelia were detected in the serum of five par- ticipants, four of whom reported recent illness. Seropositive employees entered sig- nificantly more caves (Median 25 [SD: 15] versus Median 4 [SD: 16], p = 0.04) than seronegative employees. Six caves were entered more frequently by seropositive employees posing a potentially high risk. Several of these caves were in public use areas and were opened for tours. Education of area healthcare providers about TBRF and prevention recommendations for cavers and the public are advised. KEYWORDS Borrelia, Borrelia hermsii, Borrelia turicatae, TBRF, TX 1 | INTRODUCTION cabins (Dworkin, Shoemaker, Fritz, Dowell, & Anderson, 2002). -
Serological Detection of Tick-Borne Relapsing Fever in Texan Domestic Dogs
RESEARCH ARTICLE Serological detection of Tick-Borne Relapsing Fever in Texan domestic dogs Maria D. Esteve-Gasent1*, Chloe B. Snell1¤, Shakirat A. Adetunji1, Julie Piccione2 1 Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America, 2 Texas A&M Veterinary Medical Diagnostic Laboratory, College Station, Texas, United States of America ¤ Current address: Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Baton Rouge, Louisiana, United States of America * [email protected] a1111111111 a1111111111 a1111111111 a1111111111 Abstract a1111111111 Tick-Borne Relapsing Fever (TBRF) is caused by spirochetes in the genus Borrelia. Very limited information exists on the incidence of this disease in humans and domestic dogs in the United States. The main objective of this study is to evaluate exposure of dogs to Borre- lia turicatae, a causative agent of TBRF, in Texas. To this end, 878 canine serum samples OPEN ACCESS were submitted to Texas A&M Veterinary Medical Diagnostic Laboratory from October 2011 Citation: Esteve-Gasent MD, Snell CB, Adetunji SA, to September 2012 for suspected tick-borne illnesses. The recombinant Borrelial antigen Piccione J (2017) Serological detection of Tick- glycerophosphodiester phosphodiesterase (GlpQ) was expressed, purified, and used as a Borne Relapsing Fever in Texan domestic dogs. diagnostic antigen in both ELISA assays and Immunoblot analysis. Unfortunately, due to PLoS ONE 12(12): e0189786. https://doi.org/ 10.1371/journal.pone.0189786 significant background reaction, the use of GlpQ as a diagnostic marker in the ELISA assay was not effective in discriminating dogs exposed to B. -
Genetic Manipulation of the Relapsing Fever Spirochete Borrelia Hermsii Permits Novel Investigation Into the Role of Factor H Binding in Borrelial Virulence
Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2011 Genetic Manipulation of the Relapsing Fever Spirochete Borrelia hermsii Permits Novel Investigation into the Role of Factor H Binding in Borrelial Virulence Lindy Fine Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Medicine and Health Sciences Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2506 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Genetic Manipulation of the Relapsing Fever Spirochete Borrelia hermsii Permits Novel Investigation into the Role of Factor H Binding in Borrelial Virulence A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University. by Lindy M. Fine Bachelor of Arts, St. Mary’s College of Maryland, 2002 Director: Richard T. Marconi, Ph.D. Professor, Department of Microbiology and Immunology Virginia Commonwealth University Richmond, Virginia June, 2011 ii Acknowledgement I would like to dedicate this work to my family: Jack, my husband and partner in all things; my loving and supportive parents, Maureen and Gary; and my best four-legged friends, Girl and Eve, who always remind me what’s most important. iii Table of Contents